Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.
Nagasawa M, Ohkawa T, Endo A, Mitsuiki N, Ono T, Aoki Y, Isoda T, Tomizawa D, Takagi M, Kajiwara M, Morio T, Mizutani S. Nagasawa M, et al. Among authors: morio t. Int J Hematol. 2013 Nov;98(5):533-42. doi: 10.1007/s12185-013-1443-4. Epub 2013 Oct 1. Int J Hematol. 2013. PMID: 24081926
[Immunotherapy for refractory viral infections].
Morio T, Fujita Y, Takahashi S. Morio T, et al. Rinsho Ketsueki. 2018;59(2):205-215. doi: 10.11406/rinketsu.59.205. Rinsho Ketsueki. 2018. PMID: 29515076 Japanese.
Modification of cellular and humoral immunity by somatically reverted T cells in X-linked lymphoproliferative syndrome type 1.
Hoshino A, Yang X, Tanita K, Yoshida K, Ono T, Nishida N, Okuno Y, Kanzaki T, Goi K, Fujino H, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H. Hoshino A, et al. Among authors: morio t. J Allergy Clin Immunol. 2019 Jan;143(1):421-424.e11. doi: 10.1016/j.jaci.2018.07.044. Epub 2018 Oct 17. J Allergy Clin Immunol. 2019. PMID: 30342818 No abstract available.
Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.
Nishimura A, Aoki Y, Ishiwata Y, Ichimura T, Ueyama J, Kawahara Y, Tomoda T, Inoue M, Matsumoto K, Inoue K, Hiroki H, Ono S, Yamashita M, Okano T, Tanaka-Kubota M, Ashiarai M, Miyamoto S, Miyawaki R, Yamagishi C, Tezuka M, Okawa T, Hoshino A, Endo A, Yasuhara M, Kamiya T, Mitsuiki N, Ono T, Isoda T, Yanagimachi M, Tomizawa D, Nagasawa M, Mizutani S, Kajiwara M, Takagi M, Kanegane H, Imai K, Morio T. Nishimura A, et al. Among authors: morio t. J Clin Immunol. 2021 Jul;41(5):944-957. doi: 10.1007/s10875-021-00966-z. Epub 2021 Feb 1. J Clin Immunol. 2021. PMID: 33527309
Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
Tanaka Y, Sato T, Yagishita N, Yamauchi J, Araya N, Aratani S, Takahashi K, Kunitomo Y, Nagasaka M, Kanda Y, Uchimaru K, Morio T, Yamano Y. Tanaka Y, et al. Among authors: morio t. Front Immunol. 2022 Aug 23;13:993025. doi: 10.3389/fimmu.2022.993025. eCollection 2022. Front Immunol. 2022. PMID: 36081501 Free PMC article.
Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiency.
Inoue K, Tomomasa D, Nakagama Y, Takeuchi H, Tanaka Y, Tanimoto K, Kamiya T, Isoda T, Takagi M, Tanaka K, Yoshifuji K, Miwa Y, Ohnishi H, Okada S, Mori T, Yasuda S, Kido Y, Morio T, Kanegane H. Inoue K, et al. Among authors: morio t. J Infect Chemother. 2025 Feb;31(2):102577. doi: 10.1016/j.jiac.2024.12.006. Epub 2024 Dec 5. J Infect Chemother. 2025. PMID: 39645037
521 results